NCT02361424View on ClinicalTrials.gov

Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Alzheimer Disease
Interventions
DRUG

PXT00864

PXT00864 is a fixed-dose combination of baclofen and acamprosate

DRUG

placebo

Trial Locations (1)

Unknown

CMRR, Bordeaux

All Listed Sponsors
collaborator

Ascopharm Groupe Novasco

OTHER

lead

Pharnext S.C.A.

OTHER

NCT02361424 - Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD) | Biotech Hunter | Biotech Hunter